Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Intellipharmaceutics International Inc
IPCIQ
Healthcare
Biotechnology
Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this...
technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IPCIQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(0)
•••
Moddes83
X
View Profile
View Bullboard History
Comment by
Moddes83
on Jan 15, 2020 7:20pm
RE:Halted
Hi crossfit11. where did you get that information. I was waiting for the press release to come today and now I can't find any new news about IPCIF.
(14)
•••
crossfit11
X
View Profile
View Bullboard History
Post by
crossfit11
on Jan 15, 2020 2:27pm
Halted
Halted pending news
(32)
•••
Fonziee
X
View Profile
View Bullboard History
Post by
Fonziee
on Jan 15, 2020 1:18pm
Approval
FDA approval decision will be soon. Judging how bad tremorol drug was this morning and still recieved a 13-13 split decision. I don't see any issues with IPCI getting approval. Should be an easy 1
...more
(1)
•••
OK_trade
X
View Profile
View Bullboard History
Comment by
OK_trade
on Jan 14, 2020 10:09pm
RE:RE:RE:RE:FDA APPROVAL
Do you think the decision will be made public at some point tomorrow?
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 14, 2020 3:38pm
RE:RE:RE:FDA APPROVAL
If FDA didn't like this device they would have said something already like it was with the CORV' Brinavess, if they're a silent it looks like they'll approve, I'm taking a gamble
...more
(16)
•••
pecuniam
X
View Profile
View Bullboard History
Comment by
pecuniam
on Jan 09, 2020 4:52pm
RE:RE:FDA APPROVAL
Uhhhh! Today under .80 was a clear Buy!
(38)
•••
driller1a
X
View Profile
View Bullboard History
Comment by
driller1a
on Jan 03, 2020 11:28am
RE:FDA APPROVAL
Woh! This was a $45 stock 4-5 years ago. Worth holding some. Let's see what happens.
(32)
•••
Fonziee
X
View Profile
View Bullboard History
Post by
Fonziee
on Jan 02, 2020 12:22pm
FDA APPROVAL
When this stock gets fda approval on the 15th it will be worth close to $25 a share. Yes $25 a share. Even Danny Deadlock states ; "However,these are microcap lottery stocks.Should this drug get
...more
(32)
•••
AstonMartin13
X
View Profile
View Bullboard History
Comment by
AstonMartin13
on Jan 01, 2020 3:58pm
RE:Nice SP movement
Adcom meeting on the 15th. Of positive this will be a 10 bagger.
(1)
•••
OK_trade
X
View Profile
View Bullboard History
Post by
OK_trade
on Dec 31, 2019 3:07am
Nice SP movement
Anybody knows why the SP moving up? Not that I complain about it:)
(32)
•••
AstonMartin13
X
View Profile
View Bullboard History
Comment by
AstonMartin13
on Dec 16, 2019 6:08pm
RE:FDA position on Abuse Deterrent
I agree. If approved we will make lots of $$$$ the risk is worth the reward.
(1)
•••
ConcordSST
X
View Profile
View Bullboard History
Comment by
ConcordSST
on Dec 16, 2019 1:21pm
RE:FDA position on Abuse Deterrent
Actually happy this dropped so dramatically. Managed to average down my position substantially.
(27)
•••
pennyDoctor
X
View Profile
View Bullboard History
Post by
pennyDoctor
on Dec 16, 2019 11:42am
FDA position on Abuse Deterrent
Looks positive for an approval in January based on the discussions that led to the quick review date. https://www.raps.org/news-and-articles/news-articles/2019/9/fda-consults-on-abuse-deterrent-cns
...more
(32)
•••
AstonMartin13
X
View Profile
View Bullboard History
Comment by
AstonMartin13
on Dec 11, 2019 10:46am
RE:How high will this go?
Yup i agree with you. Loaded the boat at .37.
(27)
•••
pennyDoctor
X
View Profile
View Bullboard History
Post by
pennyDoctor
on Dec 09, 2019 1:59pm
How high will this go?
I understand the 10 for one consolidation last year pre consolidation the price is still only .035 cents. That said, the stock could trade into $10.00 very quickly if Aximris gets a thumbs up from the
...more
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
LEARN about a Biotech Rising to New Heights and Transforming Regenerative Medicine